scorecardresearch
Add as a preferred source on Google
Wednesday, January 7, 2026
TopicKidney patients

Topic: Kidney patients

Mega-selling weight-loss & diabetes drug now shown to reduce risk of kidney failure, deaths

Semaglutide once a week reduced risk of adverse outcomes in kidney patients by 24 percent, finds study published in The New England Journal of Medicine.

Recipient of first genetically modified pig kidney dies 2 months after procedure

‘No indication’ transplant was cause, says hospital on death of US patient Richard Slayman who made history as the first living recipient of a genetically modified pig kidney.

Diabetes drug semaglutide offers hope beyond obesity management — kidney, heart & liver health

Study by Australian & Canadian scientists, published in Kidney International, finds that drug may be effective at reducing inflammation — lowering risk of heart & kidney disease.

On Camera

How artificial intelligence is reshaping terrorism and state security risks

Terrorist groups are increasingly using AI for propaganda, recruitment and attacks, forcing states to rethink security strategies.

2025 marked key point in India’s power sector: Clean energy surge pushed coal power into rare decline

Coal-based power generation fell 3% in 2025 while renewable capacity surged to 40% of India’s installed power mix, according to India Power Sector Review 2025 by CREA.

Bangladesh-Pakistan look to expand ties to defence procurement as Dhaka shows ‘interest’ in JF-17s

Pakistan military said it has assured Bangladesh of fast-tracked delivery of Super Mushshak trainer aircraft during high level defence meet held Tuesday.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.